missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Angiotensin I Antibody (BGN/KA/4H) - BSA Free, Novus Biologicals™
Mouse Monoclonal Antibody
Brand: Novus Biologicals NB100-62344-0.025MG
This item is not returnable.
View return policy
Description
Angiotensin I Monoclonal specifically detects Angiotensin I in Human, Rat samples. It is validated for Western Blot, ELISA.
Specifications
| Angiotensin I | |
| Monoclonal | |
| 1.0 mg/mL | |
| ELISA 1:12000-1:100000 | |
| P01019 | |
| AGT | |
| Synthetic peptide corresponding to amino acids 40-49 of the angiotensinogen precursor (Swiss-Prot entry P01019) conjugated to HMW carrier protein. | |
| 0.025 mg | |
| Primary | |
| NB100-62344 is specific for Angiotensin I and does not react with angiotensin II, III or angiotensinogen in ELISA. Enzyme (ACE) into a vasoactive form called Angiotensin II which is responsible for increasing blood pressure. Angiotensin I is important in the Renin-Angiotensin-Aldosterone System (RAAS). RAAS is responsible for the regulation of blood pressure and water retention in the body. Angiotensin I is produced from a reaction between the renal enzyme Renin and angiotensinogen. It is converted by Angiotensin Converting Enzyme (ACE) into a vasoactive form called Angiotensin II which is responsible for increasing blood pressure. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG2a |
| ELISA | |
| BGN/KA/4H | |
| Unconjugated | |
| PBS with 0.09% Sodium Azide | |
| alpha-1 antiproteinase, antitrypsin, angiotensin II, angiotensinogen, angiotensinogen (serpin peptidase inhibitor, clade A, member 8), ANHU, FLJ92595, FLJ97926, pre-angiotensinogen, serine (or cysteine) proteinase inhibitor, Serpin A8, SERPINA8angiotensin I | |
| Mouse | |
| Protein A purified | |
| RUO | |
| 183 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction